Results 251 to 260 of about 482,563 (349)

Evaluating the Resilience of ESG Investments in European Markets During Turmoil Periods

Corporate Social Responsibility and Environmental Management, EarlyView.
ABSTRACT This study investigates the resilience of Environmental, Social, and Governance (ESG) investments during periods of financial instability, comparing them with traditional equity indices of the three largest economies in the European Union by gross domestic product: Germany, France, and Italy.
Barbara Iannone, Pierdomenico Duttilo, Stefano Antonio Gattone   +2 more
wiley   +1 more source

Characterizing bidirectional transitions in mild cognitive impairment and post-reversion based on longitudinal neuroimaging and cognitive assessments. [PDF]

Alzheimers Dement
Qin Y, Cui J, Chen D, Han H, Cao H, Zhang R, Zhu H, Zhang M, Yu H.   +8 more
europepmc   +1 more source

Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study [PDF]

, 2005
Claudio Babiloni, Luisa Benussi, Giuliano Binetti, Emanuele Cassetta, Gloria Dal Forno, Claudio Del Percio, Florinda Ferreri, Raffaele Ferri, Giovanni B. Frisoni, Roberta Ghidoni, Carlo Miniussi, Guido Rodriguez, Gian Luca Romani, Rosanna Squitti, Maria Carla Ventriglia, Paolo Maria Rossini   +15 more
openalex   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Effectiveness of Transcranial Stimulation on Cognitive Abilities of Older Adults with Mild Cognitive Impairment. [PDF]

J Clin Med
Muñoz-Perete JM, Cano-Sánchez J, Castellote-Caballero Y, Vico-Rodríguez P, Cano-Orihuela M, Sánchez-Alcalá M, Carcelén-Fraile MDC.   +6 more
europepmc   +1 more source

Erratum to “Structural correlates of mild cognitive impairment” [Neurobiology of Aging 25 (2004) 913–924]

, 2004
Henrike Wolf, Anke Hensel, Frithjof Kruggel, Steffi G. Riedel‐Heller, Thomas Arendt, Lars‐Olof Wahlund, Hermann‐Josef Gertz   +6 more
openalex   +1 more source

Implementation of guideline‐recommended medical therapy for patients with heart failure in Europe

ESC Heart Failure, Volume 12, Issue 2, Page 790-798, April 2025.
Abstract Physicians' adherence to guideline‐recommended heart failure (HF) treatment remains suboptimal, especially regarding the target doses. In particular, there is evidence that non‐cardiologists are less compliant with HF guideline recommendations. This is likely to have a detrimental impact on patients' survival, readmissions and quality of life.
Maurizio Volterrani, Petar Seferovic, Gianluigi Savarese, Ilaria Spoletini, Egidio Imbalzano, Antoni Bayes‐Genis, Ewa Jankowska, Michele Senni, Marco Metra, Ovidiu Chioncel, Andrew J. S. Coats, Giuseppe M. C. Rosano   +11 more
wiley   +1 more source

Connecting the dots: A narrative review of the relationship between heart failure and cognitive impairment

ESC Heart Failure, Volume 12, Issue 2, Page 1119-1131, April 2025.
Abstract Large clinical data underscore that heart failure is independently associated to an increased risk of negative cognitive outcome and dementia. Emerging evidence suggests that cerebral hypoperfusion, stemming from reduced cardiac output and vascular pathology, may contribute to the largely overlapping vascular dementia and Alzheimer's disease ...
Mauro Massussi, Maria Giulia Bellicini, Marianna Adamo, Andrea Pilotto, Marco Metra, Alessandro Padovani, Riccardo Proietti   +6 more
wiley   +1 more source

Early administration of SGLT2 inhibitors in hospitalized patients: A practical guidance from the current evidence

ESC Heart Failure, EarlyView.
Abstract Sodium‐glucose cotransporter‐2 (SGLT2) inhibitors represent one of the main cornerstones of heart failure treatment. Nevertheless, while the cardiovascular beneficial effects of these drugs have been clearly demonstrated by several clinical trials, in clinical practice, it remains challenging to identify the appropriate timing to start SGLT2 ...
Ruggero Mazzotta, Manuel Garofalo, Samuele Salvi, Matteo Orlandi, Gianluca Marcaccini, Pietro Susini, Luca Checchi, Alberto Palazzuoli, Carlo Di Mario, Maurizio Pieroni, Matteo Beltrami   +10 more
wiley   +1 more source

An Exploratory Study on Virtual Reality Technology for Fall Prevention in Older Adults with Mild Cognitive Impairment. [PDF]

Sensors (Basel)
Ip WK, Soar J, Fong K, Wang SY, James C.
europepmc   +1 more source